Boosting of Cellular Immunity against Mycobacterium tuberculosis and Modulation of Skin Cytokine Responses in Healthy Human Volunteers by Mycobacterium bovis BCG Substrain Moreau Rio de Janeiro Oral Vaccine

dc.contributor.author	Cosgrove, Catherine A.
dc.contributor.author	Castello-Branco, Luiz R. R.
dc.contributor.author	Hussell, Tracy
dc.contributor.author	Sexton, Amy
dc.contributor.author	Giemza, Rafaela
dc.contributor.author	et.al
dc.date.accessioned	2020-01-08T10:05:09Z
dc.date.accessioned	2023-04-19T01:34:39Z
dc.date.available	2020-01-08T10:05:09Z
dc.date.available	2023-04-19T01:34:39Z
dc.date.issued	2006-01-23
dc.description	An article by American Society for Microbiology	en_US
dc.description.abstract	Oral immunization of healthy adults with 107 CFU BCG Moreau Rio de Janeiro was well tolerated and significantly boosted gamma interferon responses to purified protein derivative, Ag85, and MPB70 from previous childhood intradermal BCG immunization. Oral BCG offers the possibility of a needle-free tuberculosis vaccine and of boosting the protective immunity from intradermal tuberculosis vaccines.	en_US
dc.description.sponsorship	KNUST	en_US
dc.identifier.citation	American Society for Microbiology Vol. 74, No. 4	en_US
dc.identifier.uri	https://ir.knust.edu.gh/handle/123456789/11841
dc.language.iso	en	en_US
dc.publisher	American Society for Microbiology	en_US
dc.title	Boosting of Cellular Immunity against Mycobacterium tuberculosis and Modulation of Skin Cytokine Responses in Healthy Human Volunteers by Mycobacterium bovis BCG Substrain Moreau Rio de Janeiro Oral Vaccine	en_US
dc.type	Article	en_US

Now showing 1 - 1 of 1

Name:: Boosting of Cellular Immunity against Mycobacterium tuberculosis and Modulation of Skin Cytokine Responses in Healthy Human Volunteers by Mycobacterium bovis BCG Substrain Moreau Rio de Janeiro Oral Vacci.pdf
Size:: 86.45 KB
Format:: Adobe Portable Document Format
Description:

Now showing 1 - 2 of 2